Jayanta Bhattacharyya

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Drug Administration

Hyaluronic Acid

Chronic Myeloid Leukemia

Top Venues

ACS pharmacology & translational science

ACS biomaterials science & engineering

Journal of materials chemistry. B

This page only lists publications with an associated author ORCID identifier.

Publications

Monu Pandey, Jayanta Bhattacharyya
Gut microbiota and epigenetics in colorectal cancer: implications for carcinogenesis and therapeutic intervention. Epigenomics (2024)
Durga Nandini Athmuri, Jayanta Bhattacharyya, Naresh Bhatnagar, Parvaiz Ahmad Shiekh
Alleviating hypoxia and oxidative stress for treatment of cardiovascular diseases: a biomaterials perspective. Journal of materials chemistry. B (2024)
Monu Pandey, Jayanta Bhattacharyya
Gut microbiota and epigenetics in colorectal cancer: implications for carcinogenesis and therapeutic intervention. Epigenomics 16 (6) (2024)
Monu Pandey, Jayanta Bhattacharyya
Gut microbiota and epigenetics in colorectal cancer: implications for carcinogenesis and therapeutic intervention. Epigenomics 16 (6) (2024)
Anjali Singh, Subrata Kumar Pore, Jayanta Bhattacharyya
Encapsulation of telmisartan inside insulinoma-cell-derived extracellular vesicles outperformed biomimetic nanovesicles in modulating the pancreatic inflammatory microenvironment. Journal of materials chemistry. B (2024)
Anjali Barnwal, Sanjeev Das, Jayanta Bhattacharyya
Repurposing Ponatinib as a PD-L1 Inhibitor Revealed by Drug Repurposing Screening and Validation by In Vitro and In Vivo Experiments. ACS pharmacology & translational science 6 (2) (2023)
Anjali Barnwal, Surajit Ganguly, Jayanta Bhattacharyya
Multifaceted Nano-DEV-IL for Sustained Release of IL-12 to Avert the Immunosuppressive Tumor Microenvironment and IL-12-Associated Toxicities. ACS applied materials & interfaces (2023)
Anjali Barnwal, Vidit Gaur, Anindita Sengupta, Witty Tyagi, Sanjeev Das, Jayanta Bhattacharyya
Tumor Antigen-Primed Dendritic Cell-Derived Exosome Synergizes with Colony Stimulating Factor-1 Receptor Inhibitor by Modulating the Tumor Microenvironment and Systemic Immunity. ACS biomaterials science & engineering (2023)
Anjali Barnwal, Rohini Tamang, Sanjeev Das, Jayanta Bhattacharyya
Ponatinib delays the growth of solid tumours by remodelling immunosuppressive tumour microenvironment through the inhibition of induced PD-L1 expression. British journal of cancer (2023)
Anjali Barnwal, Sanjeev Das, Jayanta Bhattacharyya
Repurposing Ponatinib as a PD-L1 Inhibitor Revealed by Drug Repurposing Screening and Validation by In Vitro and In Vivo Experiments. ACS pharmacology & translational science 6 (2) (2023)
Anjali Barnwal, Brohmomoy Basu, Aarti Tripathi, Naina Soni, Debasish Mishra, Arup Banerjee, Rajesh Kumar, Sudhanshu Vrati, Jayanta Bhattacharyya
SARS-CoV-2 Spike Protein-Activated Dendritic Cell-Derived Extracellular Vesicles Induce Antiviral Immunity in Mice. ACS biomaterials science & engineering (2022)
Ahana Banerjee, Veena Koul, Jayanta Bhattacharyya
Fabrication of In Situ Layered Hydrogel Scaffold for the Co-delivery of PGDF-BB/Chlorhexidine to Regulate Proinflammatory Cytokines, Growth Factors, and MMP-9 in a Diabetic Skin Defect Albino Rat Model. Biomacromolecules 22 (5) (2021)